Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rh2(Oct)4 Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113999214B reveals a novel Rh-catalyzed route for indole dihydrofuran derivatives, offering high stereoselectivity and cost-effective manufacturing for pharmaceutical intermediates.